Skip to Content

Baxter International, Inc.

Corporate Governance / Derivative

  • Date:
  • 10/11/2023
  • Company Name:
  • Baxter International, Inc.
  • Stock Symbol:
  • BAX
  • Class Period:
  • FROM 5/25/2022 TO 2/8/2023
  • Status:
  • Filed
  • Filing Date:
  • 7/12/2023
  • Court:
  • U.S. District Court: District of Northen Illinois

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Baxter International, Inc. (NYSE: BAX) on behalf of long-term stockholders following a class action complaint that was filed against Baxter on July 12, 2023 with a Class Period from May 25, 2022 to February 8, 2023. Our investigation concerns whether the board of directors of Baxter have breached their fiduciary duties to the company.

On February 9, 2023, after making numerous statements assuring investors that it could operate successfully despite global challenges to its supply chain, Baxter revealed that it had not achieved control over its supply chain problems and that its earnings guidance  had been unreliable for some time.
 
Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.
 
The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company concealed the true extent of the supply chain problems it was experiencing while simultaneously exaggerating its ability to maintain a healthy supply chain in the face of global pressures; (ii) as a result, the Company’s projected earnings were materially misleading during the Class Period; (iii) the foregoing, once revealed, was reasonably likely to have a material negative impact on the Company’s financial condition; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times. Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
 
If you are a long-term stockholder of Baxter, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below. There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Baxter International. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: